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ABSTRACT; 
Background; Placenta Previa is an obstetric complication that occurs in the second and third trimester of 
pregnancy. It may cause serious morbidity and mortality to the mother. This study was conducted to ascertain 
uterine curettage in placenta previa. Objective; To determine frequency of uterine curettage in patients with 
placenta previa at a tertiary care hospital. Subjects and Methods; A total 96 patients with placenta previa aged 
20 – 45 years having placenta previa were enrolled from Department of Obstetrics & Gynaecology, Nishtar  
Hospital, Multan in this cross-sectional study. Data was entered and analyzed by SPSS version 20.0. Results; 
Our study comprised of a total of 96 patients meeting inclusion criteria of our study. Mean gestational age of our 
study cases was 38.56 ± 1.25 weeks. Mean age of our study cases was 31.20 ± 4.91 years (with minimum age of 
our study cases was 24 years while maximum age was 42 years). Our study results have indicated that majority 
of our study cases i.e. 62 (64.6 %) were aged more than 30 years. Of these 96 study cases, 52 (54.2 %) belonged 
to rural areas and 44 (45.8 %) belonged to urban areas. Of these 96 study cases 58 (60.4%) were having poor 
socioeconomic status and 38 (39.6%) belonged to middle income families. Of these 96 study cases, 51 (53.1%) 
were illiterate while 45 (46.9%) were literate. Previous history of cesarean section was positive in 55 (57.3%) of 
our study cases. Mean body mass index of our study cases was 27.64 ± 2.11 kg/m2 and obesity was present in 30 
(31.3 %) of our study cases. Mean parity of our study cases was 4.18 ± 1.24 and 51 (53.1%) had parity more than 
3. Placenta previa type 1 was present in 4 (4.2%), type 2 in 29 (30.2%), type 3 placenta previa in 26 (27.1%) and 
37 (38.5%) had type 4 placenta previa. Uterine curettage was noted in 49 (51%) of our study cases.  Conclusion; 
Very high frequency of uterine curettage was noted among patients presenting with placenta previa in our study. 
Uterine curettage was significantly associated with obesity, increasing parity and type of placenta previa.  
Keywords; Placenta previa, uterine curettage, Frequency. 
 
INTRODUCTION: 
Placenta previa complicates approximately 0.3–0.5% of pregnancies with no prior cesarean delivery 1. In 
placenta previa (PP), the placenta is located over or very near the internal cervical os 2, 3. Maternal and fetal 
morbidity and mortality from PP are considerable, and associated with high demands on health care resources. 
Given the rising incidence of cesarean section combined with increasing maternal age, the number of cases of PP 
and its complications, including placenta accreta (PA), will continue to increase 4. 
The risk of developing placenta previa increase progressively with increasing in number of cesarean sections 
with ≥ 3 cesarean deliveries the chance of having previa is 37%. Other risks for placenta previa include uterine 
surgery, increasing maternal age, high parity, multi-fetal gestation, smoking and cocaine use 5. Uterine curettage 
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has been reported to be 46 % in patients with placenta previa 6. Studies have shown that placenta previa carries 
greater risks of surgical complications including obstetrics hysterectomy and massive haemorrhage requiring 
blood transfusion 7. 
Surgical injury to the bladder, viscera, and ureters and renal failure may occur. Massive obstetrical haemorrhage 
in placenta previa is associated with severe maternal morbidity and mortality worldwide accounting for 30% 
maternal deaths in Asia. There are several neonatal complications associated with placenta previa that are often 
related to prematurity 8. PP is known to be associated with prematurity. However, there is debate about the effect 
of PP on fetal growth; some studies have suggested that pregnancies with PP are at risk of low birth weight and a 
low Apgar score 9. The purpose of this study is to document current magnitude of the problem among targeted 
population. 
 
MATERIALS AND METHODS: 
A total 96 patients with placenta previa aged 20 – 45 years having placenta previa were enrolled from 
Department of Obstetrics & Gynaecology, Nishtar  Hospital, Multan in this cross-sectional study. Informed 
written consent was taken from each patient before inclusion. Detailed history and physical examination of our 
study cases was arranged by the researcher itself. These study cases/patients underwent baseline investigations 
like ultrasonography (done by a consultant Sonologist having more than 5 years) to diagnose different stages of 
placenta previa and previous history of uterine curettage. All the data was entered and analyzed by using SPSS 
version 20.0. The quantitative variables like age, BMI and gestational age were presented as mean and standard 
deviation. Frequencies and percentages were calculated for age groups, type of placenta previa, uterine curettage, 
residential status, previous history of cesarean sections and educational status. Effect modifiers like age, parity, 
obesity, residential status, type of placenta previa, previous history of cesarean sections and obesity were 
controlled through stratification and post-stratification student chi-square test was applied to see their effect on 
outcome. P-value ≤ 0.05 was considered as significant. 
 
RESULTS; 
Our study comprised of a total of 96 patients meeting inclusion criteria of our study. Mean gestational age of our 
study cases was 38.56 ± 1.25 weeks. Mean age of our study cases was 31.20 ± 4.91 years (with minimum age of 
our study cases was 24 years while maximum age was 42 years). Our study results have indicated that majority 
of our study cases i.e. 62 (64.6 %) were aged more than 30 years. Of these 96 study cases, 52 (54.2 %) belonged 
to rural areas and 44 (45.8 %) belonged to urban areas. Of these 96 study cases 58 (60.4%) were having poor 
socioeconomic status and 38 (39.6%) belonged to middle income families. Of these 96 study cases, 51 (53.1%) 
were illiterate while 45 (46.9%) were literate. Previous history of cesarean section was positive in 55 (57.3%) of 
our study cases. Mean body mass index of our study cases was 27.64 ± 2.11 kg/m2 and obesity was present in 30 
(31.3 %) of our study cases. Mean parity of our study cases was 4.18 ± 1.24 and 51 (53.1%) had parity more than 
3. Placenta previa type 1 was present in 4 (4.2%), type 2 in 29 (30.2%), type 3 placenta previa in 26 (27.1%) and 
37 (38.5%) had type 4 placenta previa. Uterine curettage was noted in 49 (51%) of our study cases. 
 
DISCUSSION; 
Placenta previa is an obstetric complication characterized by placental implantation into the lower segment of the 
uterine wall, covering whole (major) or part (minor) of the cervix10-12. It complicates 0.4% of pregnancies at 
term13, 14. Placenta previa usually presents with painless vaginal bleeding in the late second or early third 
trimester. It is diagnosed on ultrasound during the second trimester or incidentally during an operation 15-18. 
Our study comprised of a total of 96 patients meeting inclusion criteria of our study. Mean gestational age of our 
study cases was 38.56 ± 1.25 weeks. Shaikh et al 19 also reported 38 ± 1.4 years mean gestational age of the 
patients with placenta previa which is close to our study results.  
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.49, 2018 
 
61 
Mean age of our study cases was 31.20 ± 4.91 years (with minimum age of our study cases was 24 years while 
maximum age was 42 years). Our study results have indicated that majority of our study cases i.e. 62 (64.6 %) 
were aged more than 30 years. Shaikh et al 19 also reported 30.1 ± 5.6 years mean age of the patients with 
placenta previa which is close to our study results. A study conducted by Omokonye et al 18 also reported similar 
results. A study conducted by Senkoro et al 20 has also reported 29.07 ± 6.12 years mean age of the patients with 
placenta previa which is close to our study results. Nasreen et al  6 has reported similar results.  A study 
conducted by Raheel et al 21 also reported 31.09 ± 5.38 years mean age of the patients with placenta previa which 
is close to our study results.  
Of these 96 study cases, 52 (54.2 %) belonged to rural areas and 44 (45.8 %) belonged to urban areas. Of these 
96 study cases 58 (60.4%) were having poor socioeconomic status and 38 (39.6%) belonged to middle income 
families.  A study conducted by Omokonye et al 18 also reported 81.4 % women with placenta previa were from 
poor families which is in accordance with our study findings. A study conducted by Senkoro et al 20 has also 
reported 71.1 % patients with placenta previa belonged to rural areas which is in compliance with our study 
results.  
Of these 96 study cases, 51 (53.1%) were illiterate while 45 (46.9%) were literate. Previous history of cesarean 
section was positive in 55 (57.3%) of our study cases. Omokonye et al 18 also reported 47.4 % women with 
placenta previa had previous history of cesarean section deliveries which is close to our study results.  
Mean body mass index of our study cases was 27.64 ± 2.11 kg/m2 and obesity was present in 30 (31.3 %) of our 
study cases. Shaikh et al 19 also reported 28.4 ± 5.9 kg/m2 which is in compliance with our study results.  
Mean parity of our study cases was 4.18 ± 1.24 and 51 (53.1%) had parity more than 3. Shaikh et al 19 also 
reported 4.02 ± 1.2  which is close to our study results. A study conducted by Omokonye et al 18 also reported 
35.4% parity 2 – 4 and 51.2% had parity more than 5 which is in compliance with our study results. In a study 
conducted by Nasreen et al 6, 43% had parity 1 – 4 while 45 % had parity equal or more than 5 which is close to 
our study results.  
Placenta previa type 1 was present in 4 (4.2%), type 2 in 29 (30.2%), type 3 placenta previa in 26 (27.1%) and 37 
(38.5%) had type 4 placenta previa. Shaikh et al 19 also reported similar results. In a study conducted by Nasreen 
et al 6, type 1 placenta previa was noted in 7 %, type 2 placenta previa in 29 %, type 3 placenta previa in 27 % 
and type 4 placenta previa was noted in 37 % which is in compliance with our study results.  
Uterine curettage was noted in 49 (51%) of our study cases. In a study conducted by Nasreen et al, uterine 
curettage has been reported to be 46 % in patients with placenta previa 6 which in accordance with our study 
results.  
 
CONCLUSION; 
Very high frequency of uterine curettage was noted among patients presenting with placenta previa in our study. 
Uterine curettage was significantly associated with obesity, increasing parity and type of placenta previa.  
 
REFERENCES: 
1. Kancherla V1, Räisänen S1,2, Gissler M3,4, Kramer MR1, Heinonen S2,5. Placenta previa and risk of major 
congenital malformations among singleton births in Finland. Birth Defects Res A Clin Mol Teratol. 
2015;103(6):527-35.  
2. Silver RM1. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Obstet Gynecol. 
2015;126(3):654-68. 
3. Abduljabbar HS1, Bahkali NM, Al-Basri SF, Al Hachim E, Shoudary IH, Dause WR,  et al. Placenta previa. 
A 13 years experience at a tertiary care center in Western Saudi Arabia. Saudi Med J. 2016;37(7):762-6.  
4. Kassem GA1, Alzahrani AK2. Maternal and neonatal outcomes of placenta previa and placenta accreta: three 
years of experience with a two-consultant approach. Int J Womens Health. 2013;5:803-10.  
5. Lyu B1, Chen M, Liu XX. Risk factors of peripartum hysterectomy in placenta previa: a retrospective study 
of 3 840 cases. Zhonghua Fu Chan Ke Za Zhi. 2016;51(7):498-502.  
Journal of Medicine, Physiology and Biophysics                                                                                                                              www.iiste.org 
ISSN 2422-8427     An International Peer-reviewed Journal 
Vol.49, 2018 
 
62 
6. Nasreen F. Incidence, causes and outcome of placenta previa. J Postgrad Med Inst. 2011;17(1);99-104.  
7. Fan D1, Wu S, Wang W, Xin L, Tian G, Liu L, et al. Prevalence of placenta previa among deliveries in 
Mainland China: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016 
Oct;95(40):e5107. 
8. Downes KL1, Hinkle SN2, Sjaarda LA2, Albert PS3, Grantz KL4. Previous prelabor or intrapartum cesarean 
delivery and risk of placenta previa. Am J Obstet Gynecol. 2015 May;212(5):669.e1-6.  
9. Nørgaard LN, Pinborg A, Lidegaard Ø, Bergholt T. A Danish national cohort study on neonatal outcome in 
singleton pregnancies with placenta previa. Acta Obstet Gynecol Scand. 2012;91:546–551. 
10. Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of 
observational studies. J Matern Fetal Neonatal Med 2003; 13:175. 
11. Nørgaard LN, Pinborg A, Lidegaard Ø, Bergholt T. A Danish national cohort study on neonatal outcome in 
singleton pregnancies with placenta previa. Acta Obstet Gynecol Scand. 2012;91:546-51.  
12. Simon EG, Fouche CJ, Perrotin F. Three-dimensional transvaginal sonography in third-trimester evaluation 
of placenta previa. Ultrasound Obstet Gynecol. 2013;41:465-8. 
13.  Spong CY, Mercer BM, D'alton M, Kilpatrick S, Blackwell S, Saade G. Timing of indicated late-preterm 
and early-term birth. Obstet Gynecol. 2011;118:323-33. 
14.  Goodnough LT, Daniels K, Wong AE, Viele M, Fontaine MF, Butwick AJ. How we treat: transfusion 
medicine support of obstetric services. Transfusion. 2011;51:2540-8.  
15.  Ravelli AC, Jager KJ, de Groot MH, Erwich JJ, Rijninks-van Driel GC, Tromp M, et al. Travel time from 
home to hospital and adverse perinatal outcomes in women at term in the Netherlands. BJOG. 
2011;118:457-65. 
16. Vahanian SA1, Lavery JA2, Ananth CV3, Vintzileos A4. Placental implantation abnormalities and risk of 
preterm delivery: a systematic review and metaanalysis. Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S78-
90. 
17. Silver RM1. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Obstet Gynecol. 
2015 Sep;126(3):654-68. 
18. Omokanye LO1, Olatinwo AWO1, Salaudeen AG2, Ajiboye AD1, Durowade KA3. A 5-year review of pattern 
of placenta previa in Ilorin, Nigeria. Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):35-40. 
19. Shaikh S. Frequency of placenta previa in multgravida at a tertiary care hospital. Int J Curr Res Rev. 
2014;6(23):39-43 
20. Senkoro EE1, Mwanamsangu AH2, Chuwa FS1, Msuya SE3, Mnali OP1, Brown BG4, et al. Frequency, Risk 
Factors, and Adverse Fetomaternal Outcomes of Placenta Previa in Northern Tanzania. J Pregnancy. 
2017;2017:5936309. 
21. Raheel R, Tabassum R, Bhutto A, Riaz H, Hanif R. Fetal outcome in cases of placenta previa - a 
retrospective study. Med Channel Apr - Jun 2010;16(2):256-9. 
 
